US FDA News: FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine

FDA releases a new draft guidance on investigational new drug (IND) submissions for individualized ASO drug products.
Read more: FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine